Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.

Isoniemi, H; Uutela, A; Nordin, A; Lantto, E; Kellokumpu, I; Ovissi, A; Kosunen, J; Kallio, R; Soveri, L M; Salminen, T; Ålgars, A; Lamminmäki, A; Halonen, P; Ristamäki, R; Räsänen, J; Karjula, H; Vaalavuo, Y; Lavonius, M; Osterlund, P.

Br J Surg ; 108(7): 817-825, 2021 07 23.

Artigo em Inglês | MEDLINE | ID: mdl-33749772

2.

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.

Korkeila, E A; Salminen, T; Kallio, R; Mikkola, M; Auvinen, P; Pyrhönen, S; Ristamäki, R.

Support Care Cancer ; 25(9): 2771-2777, 2017 09.

Artigo em Inglês | MEDLINE | ID: mdl-28424889

3.

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.

Osterlund, P; Kinos, S; Pfeiffer, P; Salminen, T; Kwakman, J J M; Frödin, J-E; Shah, C H; Sorbye, H; Ristamäki, R; Halonen, P; Soveri, L M; Heervä, E; Ålgars, A; Bärlund, M; Hagman, H; McDermott, R; O'Reilly, M; Röckert, R; Liposits, G; Kallio, R; Flygare, P; Teske, A J; van Werkhoven, E; Punt, C J A; Glimelius, B.

ESMO Open ; 7(3): 100427, 2022 06.

Artigo em Inglês | MEDLINE | ID: mdl-35798468

4.

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer.

Ålgars, A; Lintunen, M; Carpén, O; Ristamäki, R; Sundström, J.

Br J Cancer ; 105(2): 255-62, 2011 Jul 12.

Artigo em Inglês | MEDLINE | ID: mdl-21694725

5.

Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit.

Karlsson, A; Ellonen, A; Irjala, H; Väliaho, V; Mattila, K; Nissi, L; Kytö, E; Kurki, S; Ristamäki, R; Vihinen, P; Laitinen, T; Ålgars, A; Jyrkkiö, S; Minn, H; Heervä, E.

ESMO Open ; 6(3): 100175, 2021 06.

Artigo em Inglês | MEDLINE | ID: mdl-34091262

6.

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and ¹H-MR spectroscopy compared with histology (subgroup in the RAXO trial).

Uutela, A; Ovissi, A; Hakkarainen, A; Ristimäki, A; Lundbom, N; Kallio, R; Soveri, L M; Salminen, T; Ålgars, A; Halonen, P; Ristamäki, R; Nordin, A; Blanco Sequeiros, R; Rinta-Kiikka, I; Lantto, E; Virtanen, J; Pääkkö, E; Liukkonen, E; Saunavaara, J; Ryymin, P; Lammentausta, E; Osterlund, P; Isoniemi, H.

ESMO Open ; 6(4): 100208, 2021 08.

Artigo em Inglês | MEDLINE | ID: mdl-34325107

7.

Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.

Bendardaf, R; Lamlum, H; Ristamäki, R; Korkeila, E; Syrjänen, K; Pyrhönen, S.

Acta Oncol ; 47(6): 1046-53, 2008.

Artigo em Inglês | MEDLINE | ID: mdl-17943475

8.

Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.

Bendardaf, R; Algars, A; Elzagheid, A; Korkeila, E; Ristamäki, R; Lamlum, H; Collan, Y; Syrjänen, K; Pyrhönen, S.

Oncol Rep ; 16(4): 741-6, 2006 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-16969488

9.

Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.

Joensuu, H; Ristamäki, R; Söderström, K O; Jalkanen, S.

J Clin Oncol ; 12(10): 2167-75, 1994 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-7931487

10.

Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.

Bendardaf, R; Lamlum, H; Elzagheid, A; Ristamäki, R; Pyrhönen, S.

Oncol Rep ; 14(3): 657-62, 2005 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-16077970

11.

E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.

Bendardaf, R; Elzagheid, A; Lamlum, H; Ristamäki, R; Collan, Y; Pyrhönen, S.

Oncol Rep ; 13(5): 831-5, 2005 May.

Artigo em Inglês | MEDLINE | ID: mdl-15809746

12.

Serum CD44 in non-Hodgkin's lymphoma.

Ristamäki, R; Joensuu, H; Jalkanen, S.

Leuk Lymphoma ; 33(5-6): 433-40, 1999 May.

Artigo em Inglês | MEDLINE | ID: mdl-10342571

13.

Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma.

Mäenpää, H; Ristamäki, R; Virtamo, J; Franssila, K; Albanes, D; Joensuu, H.

Leuk Lymphoma ; 37(5-6): 585-92, 2000 May.

Artigo em Inglês | MEDLINE | ID: mdl-11042519

14.

CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.

Bendardaf, R; Lamlum, H; Ristamäki, R; Pyrhönen, S.

Oncol Rep ; 11(1): 41-5, 2004 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-14654900

15.

Does soluble CD44 reflect the clinical behavior of human cancer?

Ristamäki, R; Joensuu, H; Jalkanen, S.

Curr Top Microbiol Immunol ; 213 ( Pt 3): 155-66, 1996.

Artigo em Inglês | MEDLINE | ID: mdl-8815003

16.

[From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku]. / Luuytimensiirrosta veren kantasolujen siirtoon.--Kokemukset sadan ensimmäisen potilaan autologisesta kantasolujen siirrosta Turussa.

Remes, K; Rajamäki, A; Grenman, S; Itälä, M; Kauppila, M; Nikoskelainen, J; Pelliniemi, T T; Ristamäki, R; Salmi, T T; Salmi, T; Salminen, E; Vanharanta, R; Toivanen, A.

Duodecim ; 113(3): 219-28, 1997.

Artigo em Fi | MEDLINE | ID: mdl-11370030

17.

Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.

Bendardaf, R; Lamlum, H; Ristamäki, R; Korkeila, E; Syrjänen, K; Pyrhönen, S.

Tumour Biol ; 28(4): 212-20, 2007.

Artigo em Inglês | MEDLINE | ID: mdl-17717427

18.

DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.

Buhmeida, A; Algars, A; Ristamäki, R; Collan, Y; Syrjänen, K; Pyrhönen, S.

Oncology ; 70(6): 427-37, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-17220640

19.

Serum CD44 in malignant lymphoma: an association with treatment response.

Ristamäki, R; Joensuu, H; Salmi, M; Jalkanen, S.

Blood ; 84(1): 238-43, 1994 Jul 01.

Artigo em Inglês | MEDLINE | ID: mdl-7517210

20.

CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.

Ristamäki, R; Joensuu, H; Söderström, K O; Jalkanen, S.

J Pathol ; 176(3): 259-67, 1995 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-7545748

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: